State
72,936 recalls have nationwide distribution and so reach New York. 12,903 additional recalls listed New York specifically in their distribution scope.
Of the 12,903 recalls naming New York we have scored against our rubric, 1,501 (12%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3,134 (24%) are Severe.
Which agencies issued them
These figures cover only the 12,903 recalls whose distribution notice names New York specifically. The 72,936 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Katalyst Surgical is correcting instructions for DEX Ophthalmic Tissue Forceps (Model DVF4022-25-S) due to a field safety issue related to the Instructions for Use (IFU).
Medline Industries is recalling three burn care convenience kits because calibration issues with sterilization and packaging equipment could compromise their sterility assurance level.
JB Chemicals and Pharmaceuticals Ltd is recalling Enalapril Maleate 20 mg tablets nationwide due to out-of-specification results in organic impurities testing. Affected lot GEH25023 was distributed nationwide.
Katalyst Surgical is issuing a field safety corrective action for instructions for use (IFU) in DEX Ophthalmic Tissue Forceps, 25ga DEX Nano Tapered AWH (Model DVF4005-25).
Katalyst Surgical is issuing a Field Safety Corrective Action for DEX Ophthalmic Tissue Forceps (Model DVF4034-25-S) due to instructions-for-use (IFU) corrections needed.
DFI Co., Ltd. is recalling its Uric Acid in vitro diagnostic test (REF: 31H0P) because the devices were distributed without required FDA premarket clearance or approval.
Katalyst Surgical is issuing a Field Safety Corrective Action for 670 units of DEX Ophthalmic Tissue Forceps (Model DVF4019-25) due to updates required in the instructions for use. The device was distributed worldwide.
Katalyst Surgical is issuing a corrective action for instructions in DEX Ophthalmic Tissue Forceps (Model DVF4014-25-S). The recall affects 80 units distributed worldwide including the US and Peru, Argentina, South Korea, Japan, and France.
Katalyst Surgical is issuing a field safety corrective action for DEX Ophthalmic Tissue Forceps (Model DVF4019-25-S) due to instructions for use updates. The recall affects 645 units distributed nationwide in the US and internationally.
DFI Co., Ltd. is recalling the One Step 10A in vitro diagnostic test because it was distributed without required FDA premarket clearance or approval. The recall affects 6533 units distributed nationwide in Florida, Pennsylvania, and England.
Medline Industries is recalling certain surgical packs because calibration issues with sterilization and packaging equipment may have affected sterility assurance. All recalled units were exposed to validated sterilization cycles but the calibration problems could impact sterility integrity.
Breckenridge Pharmaceutical is recalling Duloxetine Delayed-Release Capsules 60mg due to the presence of N-nitroso-duloxetine impurity above FDA recommended limits. The affected product was distributed nationwide.
Katalyst Surgical is correcting the instructions for use (IFU) for DEX Ophthalmic Tissue Forceps (Model DVF4019-27) and related scissors due to a field safety issue.
Ajanta Pharma Ltd. is recalling Duloxetine Delayed-Release Capsules, 60 mg (Lot PA07434, expiration May 2026) because testing found N-nitroso-Duloxetine impurity above the FDA recommended limit of 0.83 ppm.
Christopher Ranch Peeled Garlic 6 oz is being recalled over potential contamination with Clostridium botulinum, due to a risk of temperature abuse during chilled storage at the firm.
Spacelabs Healthcare is recalling 57 SL Command Module (Model 91496) patient monitoring devices due to a manufacturing issue with the electrical leakage tester that could affect device safety and performance.
Orthorebirth Co Ltd is recalling ZENBONE resorbable bone void filler because the product falls outside standard specifications. The recall affects specific lot numbers distributed nationwide in California and Florida.
DFI Co., Ltd. is recalling One Step K in vitro diagnostic test devices (761 units) because they were distributed without required FDA premarket clearance or approval.
Unichem Pharmaceuticals USA Inc. is recalling Buspirone Hydrochloride Tablets, USP, 5 mg because the drug is subpotent. The recall affects approximately 10,875 bottles distributed nationwide.
Ford is recalling certain 2021-2022 Bronco vehicles because Molded-In-Color hardtop roof panels may have been manufactured improperly, allowing outer sections to detach.
Jaguar Land Rover is recalling certain 2026 Range Rover Velar, Range Rover Sport, and Range Rover vehicles because the seat belt warning chime may not sound when occupants are unbuckled, increasing crash injury risk.
Hiab USA Inc. is recalling certain Waltco MDV series liftgates because deck pins may break, causing the platform to fall and increasing injury risk.
Ford is recalling 2026 Escape and Lincoln Corsair vehicles because the park module may fail to lock, increasing the risk of the vehicle rolling away and causing a crash.
Piaggio Group Americas is recalling 285 specific Vespa models because the rearview mirrors lack the required convex mirror warning text.
Nova Bus is recalling certain LFS transit buses because the driver's speaker hole door may lack the prime glazing manufacturer DOT code mark, breaching FMVSS 205.